| Website | atlasgenetics.com |
| Category | BioTech |
| Phone | 44-(0)1173-445085 |
| Employees | |
| Founded | 2005 |
| TOTAL | $27.4M |
| VENTURE FUNDING TOTAL | $27.4M |
| Series B, 7/11 Novartis Venture Fund Life Sciences Partners BB Biotech Ventures Johnson & Johnson Development Consort Medical | £16.9M |
Atlas Genetics Ltd develops ultra rapid point-of-care (POC) diagnostic tests for infectious diseases. The VeloxTM system uses patented technology based on the use of a novel electrochemical sensor that combines speed, accuracy and multiplex detection capability. The Company has its head office in Bristol, UK, and laboratory facilities in Trowbridge, Wiltshire, UK. The Company was established in 2005 and has been financed by VC, corporate and private investors including YFM (through the South West Venture Fund) and Consort Medical plc.
